REDEFINE Triple Defense
NDC 14222-2251, AVOBENZONE, OCTISALATE, OCTOCRYLENE, cream, from Rodan & Fields.
- Product NDC
- 14222-2251
- Status
- Listed
- Labeler
- Rodan & Fields
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/14222-2251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTOCRYLENE.07 g/mL
- OCTISALATE.05 g/mL
- AVOBENZONE.03 g/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 14222-2251-1 | 14222225101 | 1 JAR in 1 CARTON (14222-2251-1) / 30 mL in 1 JAR |
| 14222-2251-2 | 14222225102 | 1 JAR in 1 CARTON (14222-2251-2) / 7 mL in 1 JAR |
| 14222-2251-3 | 14222225103 | 2 mL in 1 PACKET (14222-2251-3) |
| 14222-2251-4 | 14222225104 | 1 JAR in 1 CARTON (14222-2251-4) / 15 mL in 1 JAR |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 14222-2251 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/14222-2251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 14222-2251. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.